Electrotherapy Systems Market is expected to reach US$ 9.24 Billion by 2031

Spinal Cord Stimulator Segment Drives Electrotherapy Systems Market Growth

According to our new research study named "Electrotherapy Systems Market Forecast to 2031 – Global Analysis – by Product, Application, End User, and Geography," the market was valued at US$ 4.94 billion in 2024 and is projected to reach US$ 9.24 billion by 2031; it is expected to register a CAGR of 9.4% during 2025–2031. The growing prevalence of chronic pain and musculoskeletal disorders and increasing geriatric population drive the adoption of electrotherapy systems. The surging popularity of wearable and portable devices is projected to bring new electrotherapy systems market trends in the coming years.

Electrotherapy has been employed to treat various health issues, including pain, muscle weakness, or nerve disorders, via precise stimulation and physiotherapy using electricity. The rise of chronic pain cases fuels the global electrotherapy systems market. Moreover, an increase in the elderly population, technological advancements in the electrotherapy field, and the rise in demand for non-invasive treatment methods are also important factors contributing to the growing electrotherapy systems market size.

Electrotherapy Systems Market, by Region, 2024 (%)

Source: The Insight Partners Analysis

Electrotherapy Systems Market Analysis Based on Segmental Evaluation:

Based on product, the electrotherapy systems market is segmented into spinal cord stimulator, transcutaneous electrical nerve stimulation, interferential current therapy, electro-acupuncture, PENS, micro-current therapy, pulsed short wave diathermy, transcutaneous spinal electroanalgesia, and others. The spinal cord stimulator segment held a significant electrotherapy systems market share in 2024. The market growth of the segment can be attributed to the increased incidence of chronic pain, advancements in technology, a rise in patient preference for non-opioid therapies, and a greater inclination toward the adoption of minimally invasive procedures in the elderly population.

The geographical scope of the electrotherapy systems market report includes assessing the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. North America dominated the electrotherapy systems market share in 2024.

The rise in noninvasive treatment options in the region and the increasing prevalence of chronic pain conditions, musculoskeletal disorders, and sports injuries are driving the electrotherapy systems market growth in North America. The report “Chronic Pain and High-impact Chronic Pain in US Adults 2023” reveals that 24.3% of US adults had chronic pain, while 8.5% of adults had chronic pain that frequently restricted their life or work activities. The aging population in the US is increasingly susceptible to arthritis and nerve-related conditions, which supports the growth of the electrotherapy systems market in North America.

Moreover, the region is favored by robust healthcare infrastructure and high healthcare expenditure,  allowing the use of advanced medical devices on a wide scale. Technological progress in electrotherapy systems, such as portable and wearable devices, has spread out the patient base, contributing to the growth of electrotherapy systems market.

Patients and healthcare professionals are becoming increasingly aware of the benefits of electrotherapy, such as pain relief, a reduced need for medications, and faster rehabilitation. Furthermore, the presence of key market players in the US and Canada and the ongoing research and development programs in these countries play a significant role in the market growth by increasing the number of products that feature the latest technologies. The trend of non-pharmacological therapies amid concerns about opioid dependency has led to an increase in interest in electrotherapy as a safer alternative, which further boosts the electrotherapy systems market growth.

Regulatory approvals from the FDA are essential, as demonstrated by Medtronic's January 2022 clearance for the Intellis and Vanta neurostimulators, which target chronic pain from diabetic peripheral neuropathy. This clearance simplifies market access and helps build trust among consumers. The trend of portable and wearable devices is compatible with the changing preferences of patients for care to be given at home; therefore, clinic visits are less frequent for patients with neurological conditions or who are less mobile. At the same time, this supports value-based healthcare models.

Enovis Corp, Omron Healthcare Inc., BTL, Abbott Laboratories, Boston Scientific Corp., Allevia Health Inc., Medtronic Plc, Zynex Inc., BioWave Corp., and NeuroMetrix Inc. are among the leading companies profiled in the electrotherapy systems market report.

Based on product, the electrotherapy systems market is segmented into spinal cord stimulator, transcutaneous electrical nerve stimulation, interferential current therapy, electro-acupuncture, PENS, micro-current therapy, pulsed short wave diathermy, transcutaneous spinal electroanalgesia, and others. In terms of application, the market is segmented into pain management, neuromuscular dysfunction, sports injury treatment, iontophoresis, urinary and fecal incontinence, acute & chronic edema, and others. By end user, the market is categorized into hospitals, clinics, long term care centers, rehabilitation centers, and others. Geographically, the electrotherapy systems market is categorized into North America (US, Canada, and Mexico), Europe (France, Germany, UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), the Middle East and Africa (Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East and Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).

Contact Us

Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com